Head-to-Head

Immunic, Inc. Common Stock vs. Johnson & Johnson

IMUX

Immunic, Inc. Common Stock

$8.08 +1.25%

VS JNJ

Johnson & Johnson

$271.04 +0.86%

Johnson & Johnson (JNJ) comes out ahead, leading on 2 of 2 compared factors.

Size & Scale

IMUXJNJ
Market Cap $108.88 million $652.48 billion

JNJ leads on 1 of 1 size & scale factors.

Dividend

IMUXJNJ
Dividend Yield — 1.98%

IMUX and JNJ split the dividend factors evenly.

Risk & Sentiment

IMUXJNJ
Short Interest 2.84% 0.67%

JNJ leads on 1 of 1 risk & sentiment factors.

Dig deeper: IMUX overview, IMUX financials, JNJ overview, JNJ financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.